Press Releases

January 30, 2023

Alto Neuroscience Announces $60 Million in Additional Financing

January 10, 2023

Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression

December 23, 2022

Alto Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 14, 2022

Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations

December 8, 2022

Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology

November 15, 2022

Alto Neuroscience Wins 2022 BioTech Breakthrough and BioSpace’s 2023 Best Places to Work Awards

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Receive updates from Alto

Thanks for signing up!

Oops! Something went wrong while submitting the form.

© Alto Neuroscience 2022